Source: Annual Congress 2010 - Research development in exercise and gas exchange
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Miki, R. Maekura, T. Hiraga, H. Hashimoto, S. Kitada, M. Miki, K. Yoshimura, Y. Tateishi, M. Motone, N. Nagaya, K. Kangawa (Toyonaka, Suita, Japan). Effects of ghrelin administration in cachectic patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 1957

Member's Comments

No comment yet.

Related content which might interest you: Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010 Year: 2010 Effects of atorvastatin in asthmatic patients under treatment with high dose inhaled or oral steroid Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010 Effects of erdosteine on serum biomarker concentrations at COPD exacerbation Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010 Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Effects of a new walking aid on 6MWD in COPD patients Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers Year: 2011 Leptin, adiponectin and ghrelin levels in female patients with asthma during stable and exacerbation periods Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012 Role of obesity in asthma and COPD Source: Annual Congress 2011 - PG5 Asthma versus COPD: similarities and differences Year: 2011 Lobectomy tolerance in COPD patients Source: Annual Congress 2011 - Surgery for lung cancer: pre-operative evaluation and results Year: 2011 Serum leptin levels in asthmatic children treated with inhaled corticosteroid Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004 Measurements of urine leptin levels in OSA patients Source: Eur Respir J 2003; 22: Suppl. 45, 90s Year: 2003 Plsama leptin and TNF-a relation to nutritional parameters and elevated cost of ventilation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 36s Year: 2006 Evening administration of tiotropium during combination therapy reduces night-symptoms in COPD patients Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Sputum eosinophilia identifies systemic corticosteroid responsiveness in acute exacerbations of COPD Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases Year: 2011 Role of plasmatic leptin in response to hypercapnia in obese patients with or without OSAS Source: Annual Congress 2007 - Pathogenesis of obstructive sleep apnoea Year: 2007 The role of leptin and adiponectin in patients with COPD Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Tolerance and efficacy of slow release octreotide in idiopathic pulmonary fibrosis. The FIBROSAND study Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis Year: 2010 Plasma leptin in asthma patients with steroid induced diabetes compared with obesity patients Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007